| # | Drug | Count |
|---|---|---|
| 0 | TOCILIZUMAB | 310 |
| 1 | INFLIXIMAB | 309 |
| 2 | ETANERCEPT | 307 |
| 3 | METHOTREXATE SODIUM | 307 |
| 4 | ABATACEPT | 306 |
| 5 | ADALIMUMAB | 305 |
| 6 | SULFASALAZINE | 304 |
| 7 | ANAKINRA | 302 |
| 8 | METHOTREXATE | 292 |
| 9 | PREDNISONE | 290 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 134 | 0.5115 |
| 1 | TETANUS IMMUNE GLOBULIN (HUMAN) | 16 | 0.1468 |
| 2 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 3 | 0.0341 |
| 3 | ANAKINRA | 302 | 0.0179 |
| 4 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 139 | 0.0057 |
| 5 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 34 | 0.0053 |
| 6 | NAPROXEN SODIUM 220MG | 69 | 0.0050 |
| 7 | TRIAMCINOLONE ACETONIDE | 139 | 0.0043 |
| 8 | SULFASALAZINE | 304 | 0.0041 |
| 9 | ADALIMUMAB-FKJP | 185 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 325 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 310 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 306 |
| 3 | Aminosalicylate [EPC] | 305 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 302 |
| 5 | Corticosteroid [EPC] | 300 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 292 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 240 |
| 8 | Human Immunoglobulin G [EPC] | 85 |
| 9 | Vitamin B12 [EPC] | 62 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 302 | 0.0179 |
| 1 | Human Immunoglobulin G [EPC] | 85 | 0.0040 |
| 2 | Aminosalicylate [EPC] | 305 | 0.0030 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 310 | 0.0022 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 306 | 0.0022 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 292 | 0.0007 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 325 | 0.0003 |
| 7 | Corticosteroid [EPC] | 300 | 0.0002 |
| 8 | Vitamin D [EPC] | 62 | 0.0002 |
| 9 | Vitamin B12 [EPC] | 62 | 0.0002 |